Vivos Inc (RDGL)

[HMONNY]

Mind you, the feedback from the FDA might be for additional clinical work for the product, which the recent grant for proof of concept covers. After approval, we'd need some news about funding, partnership or even a buyout to show that the company has the finances to manufacture, market & distribute.

All the latter would be contingent of an approval. FDA approval & all else falls in place. We should be at $.01 just based on anticipation.